Great post Dryas,
I couldn't agree more about the expectations regarding funding, and if the market research that @Peeteepoo said has been received is positive and shows a potential untapped opportunity in Canine Cancer treatment then there is every chance that Vet Major could re-enter the fold around the INAD and field trial in the US.
If this was to bring upfront and milestone payments, then there will be Rocket Ships as it could help fund the Phase II in MND and some other indications such as Alzheimers and possibly trials in viruses.
Momentum is building...
Havelots
Not long now...
Great post Dryas,I couldn't agree more about the expectations...
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $86.90M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 385 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 25000 | 1 |
View Market Depth
| Last trade - 11.57am 07/05/2024 (20 minute delay) ? |
| PAA (ASX) Chart |
Day chart unavailable